Company Filing History:
Years Active: 2025
Title: Yashodhan Dilip Anaspure: Innovator in Influenza Vaccine Development
Introduction
Yashodhan Dilip Anaspure is a notable inventor based in Pune, Maharashtra, India. He has made significant contributions to the field of vaccine development, particularly in the area of influenza vaccines. His innovative work focuses on creating effective and safe vaccine compositions that can be delivered intranasally.
Latest Patents
Yashodhan holds a patent for "Stabilized live attenuated influenza vaccine compositions." This patent provides compositions and methods for manufacturing a live attenuated influenza vaccine (LAIV) that can be administered intranasally. The LAIV strains are based on cold-adapted, temperature-sensitive, and attenuated phenotypes of master donor viruses (MDVs). These strains contain the surface glycoprotein genes of wild-type pandemic or seasonal influenza strains. Importantly, the vaccine manufacturing process avoids the use of eggs and is devoid of chromatography steps. The LAIV composition includes one or more live attenuated influenza vaccine viruses and is free from polymers and surfactants.
Career Highlights
Yashodhan is currently associated with the Serum Institute of India Private Limited, a leading organization in vaccine production. His work at the institute has been pivotal in advancing vaccine technology and improving public health outcomes.
Collaborations
Yashodhan has collaborated with several professionals in his field, including Rajeev Mhalasakant Dhere and Leena Ravindra Yeolekar. These collaborations have enhanced the research and development efforts in vaccine innovation.
Conclusion
Yashodhan Dilip Anaspure is a prominent figure in the field of vaccine development, with a focus on creating effective influenza vaccines. His contributions through patents and collaborations reflect his commitment to advancing public health through innovative solutions.